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Introduction
Adult congenital heart disease (ACHD) prevalence is 
increasing over time (i.e., 119–217 cases per 100,000) and 
a further trend towards incremental medical complexity 
of this heterogeneous entity is expected (1,2). Although 
outcomes of patients undergoing surgery for CHDs 
have improved significantly over the last decades, long-
term survival even in those with the mild forms remains 
lower than that of the general population (1,3). This fact 
emphasizes the need for close clinical surveillance of ACHD 
patients to understand the reasons for increased mortality 
while most of deaths have still a cardiovascular origin (1). 
There are only limited data on the total prevalence of 
all forms of congenital aortic valve diseases. Large nation-
wide CHD databases reported mostly the prevalence of 
congenital aortic valve stenosis/left ventricular outflow 
tract (LVOT) obstruction in the range of 0.27–0.42 per 
1,000 children (1,2), and most of such patients undergo 
surgical procedures during childhood and before reaching 
adulthood. Therefore, these patients are generally not 
suitable candidates for aortic valve repair as they present 
in young adulthood due to patient-prosthesis mismatch 
(PPM) in the ACHD out-patient units. Significant PPM 
has been reported in nearly half of ACHD population 
with an aortic valve prosthesis (4) and more than half 
are classified as severe PPM which are associated with a 
significantly reduced exercise capacity (4). Complex and 
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frequently multiple redo surgical procedures are required 
in symptomatic patients with PPM to relieve the mismatch 
and to permanently reduce left ventricular afterload (5,6).  
Most of ACHD patients who have an untreated congenital 
aortic valve disease and are appropriate candidates for aortic 
valve repair surgery are those presenting with a bicuspid 
(BAV) and unicuspid (UAV) aortic valve disease (7). BAV 
disease is the most common congenital anomaly of the 
human heart with an autosomal dominant inheritance pattern 
and reduced penetrance (8). The prevalence of BAV has been 
historically quoted in the range between 1% and 2% with an 
obvious male preponderance (9,10). However, these estimates 
are predominantly derived from necropsy studies from an 
earlier era and therefore may be unreliable. Furthermore, 
transthoracic echocardiographic surveys are limited by the 
fact that the sensitivity of transthoracic echocardiography 
to identify BAV is dependent on the specific expertise of 
investigator and has been reported in the range of 50–60% 
(11,12). Moreover, BAV disease may be associated with 
some familial and endemic clustering and reveal potential 
accumulation in certain geographic areas (13,14). Therefore, 
the true BAV incidence in the general population is still 
unknown and may be underestimated due to the above-
mentioned limitations. 
UAV disease is much more infrequent disease as 
compared to the BAV entity and is found in only 0.02% 
in the echocardiographic referral population and in 4–6% 
of surgical patients undergoing aortic valve surgery for 
aortic valve stenosis (15). UAV patients have several specific 
phenotypic characteristics which differ from the standard 
BAV cohorts and present usually with a mixed aortic 
valve lesion earlier in their lives for the first aortic valve 
intervention (15). 
Quadricuspid aortic valve (QAV) is even more rare 
disorder that has been mostly described as a medical 
curiosity in the surgical and echocardiographic literature 
(16,17). Surgical experience in QAV disease is limited to 
only several case reports and small surgical case series (18) 
and therefore will be included in the review for the sake of 
completeness. 
This focused mini-review describes current treatment 
strategies of adult congenital aortic valve disease (i.e., 
BAV, UAV, QAV) with a special focus on aortic valve 
repair strategies. New perioperative aspects of surgery for 
congenital aortic valve diseases will be addressed which may 
be of value in the contemporary treatment strategies of the 




Until July 2018, a systematic literature search was 
performed on PubMed, Embase, Ovid and Google Scholar 
databases by using the following terms: aortic valve repair, 
bicuspid aortic valve, unicuspid aortic valve, QAV, aortic 
stenosis or regurgitation, adult congenital aortic valve 
disease, valve sparing aortic root replacement and aortic 
valve reconstruction. The search was limited to original 
adult human studies, and papers selected were published in 
English at any date. All abstracts were reviewed to assess 
whether the article met the inclusion criteria of (I) aortic 
valve repair in (II) adult congenital aortic valve disease (i.e., 
BAV, UAV, or QAV). The key inclusion criterion was that 
any kind aortic valve repair was performed in congenital 
aortic valve lesion associated with an aortic regurgitation 
or/and stenosis. After this preselection process, a manual 
search of the reference lists of all eligible articles was 
performed. Two authors (i.e., E Girdauskas and J Petersen) 
assessed the methodological quality of the full-text articles 
prior to final inclusion in the manuscript. 
Why to repair aortic valve in ACHD?
Major advantages of aortic valve preserving surgery result 
from the inherent limitations of artificial valve prostheses 
in valve replacement techniques. First, mechanical and 
biological aortic valve substitutes are far from perfect in 
adolescents and young adult patients as they introduce new 
concurring risks of anticoagulation-related complications 
and structural valve degeneration that have a major impact 
on the long-term survival and freedom from cardiovascular 
events (7). Mechanical aortic valve replacement has been 
shown to have an inferior long-term prognosis in young 
adult patients, as it is associated with a 27% risk of severe 
prosthesis-related complications—composite endpoint of 
death, prosthesis dysfunction, thromboembolic events, 
endocarditis, thrombosis of the mechanical prosthesis, and 
severe bleeding requiring hospitalization and transfusion—
during the first 10 postoperative years after mechanical 
aortic valve replacement (19). The risk of reoperation on 
the mechanical aortic valve prosthesis was almost 20% 
during the first 10 postoperative years (19). Even modified 
anticoagulation regimes using modern On-X mechanical 
valve prosthesis and low-dose marcumar therapy [i.e., 
target international normalized ratio (INR) of 1.5–2.0] 
in the PROACT trial revealed still a significant risk of 
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prosthesis-related complications with a linearized rate 
of 4.4%/patient-year in a prospectively followed study 
cohort (20). Based on these data, one may summarize that 
a young ACHD patient who undergoes a mechanical aortic 
valve replacement will inevitably suffer at least one major 
prosthesis-related complication during the life-time (21). 
Bioprosthetic aortic valve substitute eliminates obviously 
the risk of anticoagulation-related bleeding events, 
introduces however the exponentially increasing risk of 
structural valve deterioration, requiring reoperation (22). 
There is an inverse relationship between age at surgery and 
the rate of degeneration of bioprostheses and at least half 
of the ACHD patients are expected to undergo reoperation 
within 8 postoperative years (22). Several studies reported 
an excess long-term mortality in young patients with aortic 
bioprostheses which was inversely proportional to the age 
of the patients at the time of surgery, i.e., younger patients 
had the highest mortality risk—and was further aggravated 
by the insertion of a small bioprosthesis (23). Valve-in-
valve transcatheter aortic valve replacement emerged as a 
novel and promising technique to address the structural 
degeneration of stented tissue prostheses, however, the 
experience with this procedure is very limited in patients 
less than 70 years old. There are some specific issues 
which might be of special relevance in the young patients 
presenting with a congenital aortic valve disease: increased 
risk of PPM with higher transvalvular gradients, risk of valve 
thrombosis due to incomplete unfolding of transcatheter 
valve-in-valve prosthesis in the stented bioprosthesis and 
the most relevant issue of the long-term durability of 
transcatheter valve-in-valve procedure in the young adults. 
Therefore, long-term durability data of TAVR prostheses 
in patients <70 years are urgently needed to answer the 
question of the appropriateness of transcatheter valve-in-
valve intervention in the setting of bioprosthetic aortic valve 
degeneration in the young adult patients presenting with 
congenital aortic valve disease.
Considering the endpoint of event-free life-expectancy 
after mechanical vs. biological aortic valve replacement, 
a meta-analysis showed a comparable event-free life-
expectancy of 11 to 12 years in a 40–50 years adult patient 
independently from the type of implanted aortic valve 
prosthesis (24). In summary, aortic valve replacement 
should be treated as a palliative procedure in young ACHD 
patients given the fact that the available prosthetic valve 
material is insufficient and basically exposes young adult 
patients to the lifetime concurring risks of anticoagulation-
related complications vs. structural valve deterioration, 
requiring reintervention. From this point of view, aortic 
valve repair with the potential of salvage of native cusp 
tissue represents a viable alternative to improve the long-
term event-free survival in ACHD patients (25). 
Principles of aortic valve repair in ACHD patients
Techniques of aortic valve repair in ACHD patients must 
respect the basic Carpentier’s principles of heart valve 
repair (26) and, therefore, to address (I) the dilated aortic 
valve annulus and (II) to restore the normal mobility and to 
recreate a sufficient coaptation line of aortic valve cusps. 
Aortic valve annulus
Aortic valve annulus has a complex semilunar shape and 
extends from the deepest cusp insertion point in the LVOT 
to the sinotubular junction (STJ) in the commissural 
area (27). Therefore, from a very practical point of view 
the dilatation of aortic valve annulus may be subdivided 
into three categories: (I) dilatation at the level of deepest 
insertion point of aortic valve cusps in the LVOT (so-called 
“aorto-ventricular junction or basal ring”) (Figure 1A), (II) 
dilatation at the STJ level (Figure 1B), and dilatation of the 
whole aortic root including basal ring and STJ (Figure 1C). 
Depending on the form of aortic valve annular dilatation, 
annuloplasty is performed using a specific technique. 
In ACHD patients with an isolated dilation of the basal 
ring (Figure 1A) suture (28) or ring annuloplasty (29) is 
performed at the level of basal ring. Patients with STJ 
dilatation (Figure 1B) have mostly a concomitant ascending 
aortic aneurysm and STJ reduction is achieved by using 
an ascending aortic graft prosthesis with an appropriate 
diameter. In case of annular dilatation involving the 
whole aortic root (Figure 1C) valve sparing root surgery 
(i.e., reimplantation or remodeling) is performed and 
stabilizes both annular components at the level of basal ring 
as well as STJ. 
Cusp disease
Cusp disease in aortic regurgitation patients is subdivided 
according to the functional Carpentier’s classification which 
has been adopted to aortic valve disease by Dr. El Khoury 
group in Brussels (30). Based on the mobility of aortic valve 
cusps (i.e., normal, prolapse and restriction) three types 
of cusp disease can be separated which are addressed by 
specific surgical techniques (Figure 2). 
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In type I cusp disease the mechanism of aortic 
regurgitation is annulus dilatation which is addressed as 
described previously (Figure 2A). In type II cusp disease the 
cusp prolapse is corrected by central plication sutures or a 
limited triangular resection (Figure 2B). Given the absolute 
or relative lack of functioning native cusp tissue, type III 
cusp disease is the most challenging cusp pathology for 
repair procedures. Resection of the restrictive cusp tissue 
and subsequent patch augmentation is often required which 
obviously limits the durability of repair due to structural 
degradation of patch material (Figure 2C). 
Aortic valve repair in BAV disease 
BAV is a very heterogeneous entity and distinct valvulo-
aortic phenotypes have been previously reported (31). 
Valvular morphotypes of BAV have been classified 
according to the Sievers classification model that integrates 
the number of raphes (type 0, type 1, and type 2), cusp 
fusion pattern [fusion of the right- and left-coronary cusp 
(R/L), fusion of right- and non-coronary cusp (R/N)] and 
functional type of valve lesion (stenosis, insufficiency and 
mixed disease) (32). The most common form is type 1 BAV 
with a single raphe between the right and left coronary cusp 
which is associated with a stenotic lesion (i.e., Sievers type 1, 
R/L, S) and is found in more than half of all BAV patients (3). 
Furthermore, BAV has been shown to be associated with 
different types of concomitant aortopathy (33) and distinct 
classification models of aortic phenotypes have been 
developed (34,35). During the ongoing development of 
aortic valve sparing techniques in the BAV disease, more 
delicate morphologic details of BAV structure came into 
the focus of interest, especially the angle of commissural 
orientation (36), the geometric and effective cusp 
height (37), and the pathophysiological mechanism of aortic 
regurgitation. Therefore, in terms of BAV treatment strategy 
(i.e., repair vs. replacement), there is an urgent need to update 
the previously published BAV classification models to include 
the parameters crucial for aortic valve repair techniques. 
Despite the above-mentioned phenotypic heterogeneity 
B CA
Figure 1 Forms of aortic valve annulus dilatation in ACHD patients. (A) Dilatation of the basal ring; (B) STJ dilatation; (C) dilatation of the 
whole aortic root. ACHD, adult congenital heart disease; STJ, sinotubular junction.
793Cardiovascular Diagnosis and Therapy, Vol 8, No 6 December 2018
© Cardiovascular Diagnosis and Therapy. All rights reserved. Cardiovasc Diagn Ther 2018;8(6):789-798cdt.amegroups.com
of BAV disease (31,32), BAV patients represent the 
most common morphological substrate for aortic valve 
interventions in young adults (38). Almost one third of 
BAV patients develop a hemodynamically relevant aortic 
valve regurgitation at the mean age of 45 years and are 
faced a complex decision-making process regarding the 
most appropriate aortic valve intervention (39). Most BAV 
patients with an isolated/predominant aortic regurgitation 
are very suitable candidates for aortic valve repair strategy 
which is based on two congenital-morphologic components 
of bicuspidality which result in geometric alteration of 
functional aortic root: (I) dilatation of the aorto-ventricular 
junction (so-called “basal ring”) is a classical congenital-
morphologic feature of bicuspidality which results in 
increased shear stress on aortic valve cusps (Figure 3A); 
(II) prolapse (or restriction) of the conjoined (so-called 
“fused”) cusp which reduces effective cusp height and causes 
coaptation loss of the fused cusp (Figure 3B,C). Both above-
mentioned morphologic substrates of BAV regurgitation are 
amenable for valve sparing techniques. 
Additionally, one half of all BAV regurgitation patients 
have a concomitant proximal aortopathy which enlarges 
significantly the diameter of STJ and thereby aggravates 
further geometric alterations of the functional aortic root. 
The main idea of aortic valve repair strategy in BAV, 
and altogether in adult congenital aortic valve disease, is 
that the recreation of the optimal aortic root geometry—
i.e., reduction of basal ring diameter to less than 25 mm and 
restoration of effective cusp height (coaptation length) above 
8-mm—would result in the competence of aortic valve and 
the long-term stability of bicuspid architecture (40). In other 
words, the expectation is that recreation of the symmetric, 
best possible geometric configuration of the regurgitant 
BAVs will significantly reduce the degeneration rate of 
B CA
Figure 2 Types of cusp disease in ACHD patients and the corresponding surgical techniques. (A) Type I: normal cusp movement and the 
surgical technique of valve sparing root surgery. Arrow indicates Dacron prosthesis which is used for reimplantation procedure; (B) type II: 
cusp prolapse addressed by central plication of the fused cusp. Arrow indicates cusp plication in the central part of the cusp to correct the 
prolapse; (C) type III: restrictive cusp movement treated by cusp augmentation using pericardial patch. Arrow indicates decellularized bovine 
pericardial patch implantation to address cusp restriction. ACHD, adult congenital heart disease. 
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Figure 3 The most common congenital-morphologic substrate of BAV regurgitation. Arrows indicate prolapse of the fused cusp. BAV, 
bicuspid aortic valve. 
B CA
Figure 4 Recreation of the geometric configuration of the functional bicuspid aortic root. (A) Asymmetric Sievers type I R/L BAV with 
dilatation of basal ring to 34 mm, prolapse of the fused cusp (*), normal non-coronary cusp (#) and aneurysm of the aortic root which has 
been excised. Arrow indicates raphe between right and left coronary cusp; (B) valve sparing root replacement by remodeling technique (*) 
with an additional reduction of basal ring diameter to 25 mm, prolapse correction of both cusps (arrow) and recreation of the symmetric 
configuration of bicuspid valve. Cross marks indicate the bottom of right coronary ostium.
BA
bicuspid cusp tissue and improve long-term stability of such 
valves (Figure 4). Retrospective monocentric data support 
strongly this argumentation (40-42), however, has still to be 
validated by ongoing prospective multicenter trials. 
Aortic valve repair in UAV disease 
UAV is defined as aortic valve with one fully developed 
commissure and two raphes at the level of two non-functional 
commissures (15) (Figure 5).  
The published evidence in the literature suppose that 
UAV disease represent an extreme in the spectrum of adult 
congenital aortic valve disorders, as UAV patients generally 
present with a more accelerated and symptomatic aortic 
valve degeneration and stenosis at younger age as compared 
to the BAV patients (43). Most reports of UAV patients 
describe young individuals with advanced valvular disease 
that develops early and progresses at a faster rate than 
typical BAV. The challenge of aortic valve repair techniques 
in UAV patients is the absolute lack of functional aortic 
cusp tissue which is frequently very dysplastic and severely 
calcified in the areas of both rudimentary commissures 
(i.e., type III cusp disease). This tissue lack results in a 
central coaptation defect and a wide central jet with several 
eccentric components due to restrictive cusp movement. 
From a technical standpoint UAV can be transformed into 
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B CA
Figure 5 Echocardiographic and intraoperative appearance of the unicuspid aortic valve. Red arrows indicate: (A) two fused commissures 
and a typical posterior opening towards the left atrium of UAV in a transesophageal echocardiographic image; (B,C) and the intraoperative 
appearance of unicuspid aortic valve before and after excision during the surgery.
a symmetric BAV morphology using an augmentation 
patch (i.e., autologous pericardium or decellularized 
bovine pericardium) to reconstruct the second functional 
neo-commissure, as published by Dr. Schäfers group in 
Homburg (44) (see Figure 2C). However, patch repair has 
been shown to be a risk factor that reduces repair durability 
and is driven by the structural deterioration of the patch 
material. Nonetheless, in growing patients with small 
LVOT and aortic annulus diameter UAV repair even with a 
patch represents a viable treatment option because it allows 
the native annulus to grow normally and thereby prevents 
PPM occurrence. This strategy also allows the eventual 
Ross operation to be delayed to an adulthood where the 
pulmonary homograft is better tolerated. 
QAV and the preliminary experience with repair 
techniques
QAV is a very rare cardiac condition with a reported 
prevalence of 0.008% to 0.46% depending on the study 
population analyzed. The functional status of QAV is 
predominantly regurgitant (45), however, the experience 
with aortic valve sparing techniques in the setting of 
regurgitant QAV is still limited to few published case 
reports and no systematic reconstruction approach 
has been yet developed. Depending on the specific 
morphologic characteristics of QAV a tricuspidalization vs. 
bicuspidalization repair strategy has been proposed for QAV 
repair with a varying success (46-48).  
Minimally invasive approach in aortic valve 
repair of ACHD patients
 
The ongoing development of surgical technologies, routine 
implementation of the intraoperative transesophageal 
echocardiography monitoring and the growing experience 
with video-assisted surgery allowed the standard use of 
limited surgical approaches in aortic valve surgery. Standard 
use of the partial upper sternotomy in the 3 or 4. intercostal 
space reduce significantly surgical trauma and provides an 
excellent access to the aortic valve and the proximal aorta and 
thereby enables the whole spectrum of surgical procedures on 
the aortic valve and the aortic root/ascending aorta (Figure 6). 
In addition to the superior cosmetic result and the reduction 
of sternal wound complications after the minimally-
invasive surgery, recent meta-analysis of randomized trials 
documented reduced postoperative blood loss and lower need 
for blood transfusion in the partial sternotomy subgroup 
vs. conventional sternal access (49). Even if the hard study 
endpoints—i.e., hospital mortality, stroke, cardiovascular 
complications, renal failure as well as ICU and hospital 
stay—were not significantly different between the partial 
vs. full sternotomy subgroups in the published prospective 
randomized trials (50,51), the standard use of minimally-
invasive approach did not negatively affect the safety profile 
of aortic valve surgery. From our personal point of view, 
even the evidence of non-inferiority of minimally-invasive 
approaches in aortic valve repair surgery in ACHD patients 
legitimates the routine use of limited surgical access in the 
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B CA
Figure 6 Complex aortic valve repair using a partial upper sternotomy approach.
daily practice of aortic valve/aortic root surgery and results in 
better patients’ acceptance.
Summary
Surgical treatment of adult congenital aortic valve diseases, 
and especially aortic valve sparing techniques underwent 
major development during the last decades and improved 
significantly the outcomes and quality of life of such 
patients. Specific surgical strategies have been developed to 
address BAV and UAV disease and to avoid the life-long risk 
of prosthesis-associated complications of mechanical and 
biological aortic valve substitutes in young adult population. 
This mini-review discussed new treatment aspects of aortic 
valve lesions in ACHD patients and presented current 
scientific evidence for aortic valve sparing techniques 
and shed some light on the future developments in this 
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